Sign in

    Eric Wong

    Vice President and Equity Research Analyst at The Goldman Sachs Group, Inc.

    Eric Wong is a Vice President and Equity Research Analyst at The Goldman Sachs Group, Inc., specializing in covering the U.S. utilities, independent power, and renewable energy sectors. He provides detailed coverage of companies such as NextEra Energy, Dominion Energy, Exelon, and NRG Energy, with a track record of delivering actionable investment advice and maintaining a success rate above 60% on platforms like TipRanks, as well as generating positive returns for investors. Wong began his career in the financial services industry in the early 2010s and has held analyst roles at J.P. Morgan before joining Goldman Sachs in 2018. He holds FINRA Series 7 and 63 licenses and is recognized for his analytical rigor and contributions to sector research.

    Eric Wong's questions to Kymera Therapeutics (KYMR) leadership

    Eric Wong's questions to Kymera Therapeutics (KYMR) leadership • Q4 2024

    Question

    Eric Wong of The Goldman Sachs Group, Inc. inquired about Kymera's strategy for strategic partnerships beyond the Sanofi deal, particularly asking about the criteria for selecting partners for its oncology assets.

    Answer

    CEO Nello Mainolfi stated that the immunology pipeline will be advanced independently for now. For oncology, he reiterated the strategy to partner programs after Phase I. The criteria for a partner is a 'win-win' situation with a company that is driven, interested, and has the capabilities to successfully develop the asset.

    Ask Fintool Equity Research AI